CBD is a remarkably medically potent component of marijuana. One of over 60 cannabinoids, CBD, short for ‘cannabidiol,‘ has dozens of medical uses, including anti-seizure, anti-inflammation, anti-anxiety, antioxidant, anti-tumor and as treatment for pain. But new research confirms what has long been thought: CBD in addition to other entourage cannabinoids like THC is far superior medically to pure CBD.
Cannabidiol does not produce the ‘high’ associated with THC, another medically useful cannabinoid. This lack of psychotropic effect from CBD is highly esteemed by researchers (and politicians), if not necessarily by the patient.
Dr. Sanjay Gupta brought to awareness for many Americans his conversion to supporting medical cannabis and research and reporting on CBD treatment of intractable seizures in children. The effectiveness of CBD to quiet seizures heretofore unstoppable by a flood of truly toxic drugs has led to the spectacle of, in America, of medical refugees having to leave their harsh home states and head to legal Colorado.
In the USA many state legislators, although often abhorrent to marijuana, have been unable to resist the logic of supplying this safe but effective anti-seizure medication to children in their states. Sometimes shamed by families testifying with their seizure-inflicted chidren many states have passed CBD-only (or low THC) availability laws. (Bizarrely, by doing so, states are violating federal law, as CBD remains a Schedule I substance, deemed harmful and without medical value, and most worthy of harsh control. But that remains topic for another day.)
The danger here is that state legislators may then feel that they have done their part in supplying medical marijuana by giving CBD the OK, will resist widening choices even in light of evidence that “entourage” cannabis medications are superior.
The Israeli research, with important implications for dosing medical cannabis is linked below. It will soon be detailed in another post: